Chapter 4. Environmental and Regulatory Aspects

  1. Dr. Peter J. Dunn3,4,
  2. Dr. Andrew S. Wells5 and
  3. Dr. Michael T. Williams6
  1. David Taylor1 and
  2. Vyvyan T. Coombe2

Published Online: 19 MAR 2010

DOI: 10.1002/9783527629688.ch4

Green Chemistry in the Pharmaceutical Industry

Green Chemistry in the Pharmaceutical Industry

How to Cite

Taylor, D. and Coombe, V. T. (2010) Environmental and Regulatory Aspects, in Green Chemistry in the Pharmaceutical Industry (eds P. J. Dunn, A. S. Wells and M. T. Williams), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527629688.ch4

Editor Information

  1. 3

    Pfizer Green Chemistry Lead, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

  2. 4

    Pfizer Global Research and Development, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK

  3. 5

    Astra Zeneca, Process Research & Development, Bakewell Road, Loughborough, LE11 5RH, United Kingdom

  4. 6

    CMC Consultant, 133, London Road, Deal, Kent, CT14 9TY, United Kingdom

Author Information

  1. 1

    WCA Environment Ltd, Brunel House, Volunteer Way, Farington, Oxfordshire SN7 7YR, UK

  2. 2

    AstraZeneca Gloal SHE, Brixham Environmental Laboratory, Freshwater Quarry, Brixham, Devon, TQ5 8BA, UK

Publication History

  1. Published Online: 19 MAR 2010
  2. Published Print: 10 MAR 2010

ISBN Information

Print ISBN: 9783527324187

Online ISBN: 9783527629688

SEARCH

Keywords:

  • environmental pollution;
  • persistence;
  • bioaccumulation;
  • ecotoxicology;
  • product regulations;
  • process regulations;
  • chemicals control regulations;
  • pollution control regulations;
  • environmental quality regulations

Summary

This chapter contains sections titled:

  • Historical Perspective

  • Pharmaceuticals in the Environment

  • Environmental Regulations

  • A Look to the Future

  • References